Novocure Trials – Cancer Clinical Trials
Overview
Novocure® is developing TTFields for different cancer diseases. This website is designed to assist patients, their family members, and caregivers in accessing clinical study sites for potential participation in ongoing studies.
TTFields are electric fields that disrupt cancer cell division. TTFields are delivered to the region of the cancer using a lightweight, battery-operated medical device. The device applies TTFields non-invasively, and gives patients the option to maintain their lifestyle while receiving TTFields treatment.
The use of TTFields has been approved by the FDA via the Premarket Approval Pathway for the treatment of GBM, together with temozolomide. TTFields therapy has obtained a CE mark in Europe, and is approved in Japan for the same indication. TTFields are experimental for all indications mentioned in these clinical studies and has not been approved for their treatment.
Clinical Studies Currently Enrolling
KEYNOTE D58
Glioblastoma
LUNAR-2
Lung cancer
LUNAR-4
Lung Cancer
Clinical Studies - Enrollment Complete:
TRIDENT
Glioblastoma
PANOVA-4
Metastatic Pancreatic cancer
PANOVA-3
Pancreatic cancer
EF-33
Glioblastoma
LUNAR
Lung Cancer
ZL-8301-001
Gastric cancer
METIS
Brain Metastasis
KEYNOTE B36
Lung Cancer
Find Cancer Clinical Trials
The best way to learn more about eligibility for one of our trials is to contact a study center near you. To filter study results by condition or trial: fill in the fields below, enter your location, and click “find trials”. Click the trial icon to visit the study page, and learn more about that trial.